Other advances in recent years include so-called targeted treatments that take aim at the underlying genetic mutations that fuel tumor growth drugs like Roche Holding AG's Zelboraf for melanoma.
WSJ: New Cancer Drugs Use Body's Own Defenses
2.
Examples include Gleevec, Zelboraf, and Xalkori.
FORBES: Hacking the President's DNA: When Synthetic Biology Meets National Security